TickerFacts.

Inhibikase Therapeutics, Inc. (IKT): Long-Term Debt

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Long-Term Debt is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$381.8K
As of 2023-12-31
2021-12-31: $248.9K2023-12-31: $381.8K$381.8K
2021-12-31 Long-Term Debt (USD) 2023-12-31
Period endedLong-Term DebtChange YoYSource filing
2023-12-31$381.8Kn/a2024-03-27, Balance as of period end
No annual figure between 2021-12-31 and 2023-12-31.
2021-12-31$248.9Kn/a2022-03-31, Balance as of period end